SupplySide West is part of the Informa Markets Division of Informa PLC

Informa
Informa

See how professionals turned challenges into success at SupplySide Global!

Do you have an innovative ingredient that you believe is best-in-class? Ingredient Idol 2025 submissions now open!

Did you know SupplySide Global is expanding the Expo Hall? Find out all about the new Level 2 here!

Oct. 27-30, 2025
Expo Hall Oct. 29 & 30

Mandalay Bay, Las Vegas

Flagship sponsor:

Compliance FAQs

Whether you're preparing for an upcoming event or seeking guidance on marketing materials, this resource is designed to help you navigate compliance requirements effectively and avoid potential fines. Explore the sections below to learn more about how we support exhibitors in adhering to U.S. regulations and fostering industry integrity.


Review Process and Consistent Enforcement 

All ingredients offered for sale in the U.S. are regulated by the FDA, USDA, and/or FTC, regardless of whether they are sold directly to consumers. Ingredient claims must align with the intended use in the market. We use the U.S. FDA’s Compliance Guide on Structure Function claims in evaluating claims. Claims about diagnosing, treating, curing, or preventing disease could cause an ingredient to be classified as an unapproved drug. Explicit claims mention a specific disease or class of diseases such as cancer (anti-tumor), diabetes, heart disease, Alzheimer’s, Parkinson’s, osteoarthritis, COPD, fibromyalgia, ADHD, hyperthyroidism, etc. A statement is also a disease claim if it states an effect on a specific disease or class of disease by using descriptions of the disease state. Examples of such claims include and are not limited to lessens chronic or acute cough, reduces inflammation, relieves headaches, protects against tumors, stops hair loss, pain relief, antibacterial, antifungal, anti-viral, and syndromes such as IBS and Metabolic Syndrome, and/or other known symptoms of diseases. Claims are also context dependent, for instance, relief from aches or stiffness due to overexertion and exercise could be acceptable, but when these claims are associated with arthritis, the claims would be non-compliant and subject to a compliance fine (see below, What is a Compliance Fine?). Images, symbols, and vignettes can also establish an association with a disease. Structure Function claims are not acceptable for ingredients intended solely for cosmetic/topical applications.

Yes, please reference our Claims Guidance document for examples of unacceptable and acceptable claims.

Our MarketReady Insights (MRI) team is standing by to assist you. Please contact our MRI team at [email protected].

The Standards team conducts a thorough review process for exhibits, evaluating displays and marketing materials across the event floor. We sometimes ask that corrections be made during the event when our Standards team identifies highly visible non-compliance. Onsite immediate correction may include the removal of non-compliant materials from the exhibit to be returned to your booth near the end of the event, immediate revisions made to the materials (redacting/blacking out words on sell sheets to be distributed), and/or covering claims on displays and/or removal of signage. Immediate corrections at the exhibit do not always guarantee that a compliance fine will not be assessed (see below What is a Compliance Fine?). Non-compliant claims are most often addressed 1-2 weeks after the event.

The Standards team will offer general guidance. This may include instructions to remove specific claims or revise them into acceptable language appropriate to the intended use of the product. For instance, a structure function claim to support or maintain a healthy status, or any such claim that would be acceptable for a dietary ingredient product. Structure function claims are not acceptable for ingredients intended solely for cosmetic/topical applications. More comprehensive and specific recommendations can be obtained through our MarketReady Insights program.

Yes – as done for the past several years, exhibitors will receive a Standards review message identifying the non-compliant claims in the specific materials presented at the exhibit. Starting at the 2026 SupplySide Global event, reviews for this event will also include the factors used to determine compliance fines. For example, the non-compliant claims found were heart disease, reduces cholesterol, and inhibits platelet aggregation. Disease claims in the marketing. This is your first offense. {{Company name}} exhibited with regular visibility. The compliance fine will be $250.

All ingredients offered for sale in the U.S. are regulated by the FDA, USDA, EPA and the FTC (for paid advertising), regardless of whether they are sold directly to consumers. Ingredient claims must align with the intended use in the market. We rely on the U.S. FDA’s Compliance Guide on Structure Function claims in evaluating claims. Additionally, we use specialized software to help identify these types of claims. Starting at the 2026 SupplySide Global event, compliance fines will be assessed for non-compliant claims as described in question 1 above, with all potential violations requiring a final approval from a Market Integrity team manager before any fine is assessed or billed. Our entire review process follows an established Compliance program Implementation plan (select the Enforcement button). See below What is a Compliance Fine?)

To ensure consistency, we use specialized regulatory software to support our team's work. Additionally, all potential violations require a final approval from a Market Integrity manager before any fine is assessed or billed. Our Standards team members have an average of 4+ years of industry experience and undergo comprehensive preparation before reviewing exhibitor materials. Their qualifications include:

  • Formal third-party training in regulatory compliance standards

  • Ongoing support from our dedicated regulatory consulting service

  • Regular in-house training programs to stay current with evolving regulations 

You may reply directly to the Standards Specialist who sent you the compliance review. You may also contact [email protected] for any questions or concerns about a compliance matter or a fine.

The compliance fine is a calculated fine that will be billed to an exhibitor after an event who, during the event, was found to present non-compliant marketing materials at their exhibit. This includes any claims in signage at or on the booth display itself. The Standards team visits every exhibit to review marketing materials. If non-compliant claims are found at an exhibit, a review message with the details of the concerning claims and the amount of the compliance fine will be sent to the primary contact on the account within 1-2 weeks after the event. The Standards review will be followed by an invoice statement from accounting with the added line item for the compliance fine including the details of the offense 4-6 weeks after the event.

Our audience values compliance as a core part of their experience at our events, knowing product information has been properly reviewed. This results in a higher number of quality attendees as the integrity of the event increases. Currently, the Standards team identifies non-compliance at 15-19% of exhibits at SupplySide events. Without consequences for displaying non-compliant materials, there is less incentive for exhibitors to ensure regulatory compliance. Our goal is to enhance industry self-regulation while reducing non-compliant materials at our events, which directly contributes to the quality and credibility of our shows and upholds the high standards of our exhibitors.

To support the Compliance Fine initiative, we're adding a pre-screening process to the Compliance program. This optional service allows us to assist exhibitors in identifying potential issues early, helping them avoid any fines. The pre-screening process will be particularly valuable for our international exhibitors who must navigate U.S. regulations when bringing their products to the U.S. market.


Complimentary Pre-Screening (avoiding a compliance fine) 

The SupplySide events do not have a pre-approval application process for new exhibitors (or returning exhibitors) to get approved prior to reserving a booth for an event. To assist all SupplySide exhibitors, we are implementing a new pre-screening process that allows you to reserve your booth first and then provide the marketing materials you intend to present at your exhibit. The Standards team will provide a brief compliance review indicating any claims that could potentially result in a compliance fine. These pre-screen reviews are not to ensure full compliance with all U.S. regulations applicable to the products. These pre-event reviews are to identify examples of potential non-compliant claims and the eligibility of the marketing materials to be presented at SupplySide events and offer potential avoidance of any compliance fines after the event.

*** If your company is located outside of the U.S., we highly recommend you go through our Pre-screening process before the event. ***

The Standards team will formally begin pre-screening for the 2026 SupplySide Global event after November 17, 2025. You can submit your marketing materials to [email protected] to us after this date. There is no additional cost to have your marketing pre-screened by our Standards team for an eligibility review prior to the event. Within 5-7 business days, you should receive a report that highlights any non-compliant claims that need to be removed or revised. To ensure your marketing materials are fully compliant to U.S. regulations, and to receive specific revision recommendations, please explore our MarketReady Insights consulting services.

We are providing exhibitors with a full preparation period before any compliance fines take effect. We are announcing this Compliance program change at our 2025 event, giving you advance notice and time to prepare for the 2026 SupplySide Global event. Fines will be implemented for the 2026 SupplySide Global event and all events thereafter.

We do not offer discounts for having your product materials reviewed prior to an event.


 What Determines the Compliance Fine / Calculating the Fine  

There are three factors that are used to determine if a fine will be assessed and to calculate the amount of the fine:

  1. The presence of explicit and/or implied disease claims 
  2. The frequency of non-compliant offenses (any repeated offense history) for your company and
  3. The visibility of your company at the event (regular or premium visibility).

Compliance fines range from $250 - $1500 depending upon the three factors described above in the previous question. For example, a first offense claim is identified: “protects against tumors” (implies cancer) and the exhibit was a 10x10 inline booth (regular visibility) would be the base fine of $250. The base fee would be doubled to $500 if the exhibit had premium visibility. Repeat offenses will also double the fine for the following year and 1.5 times in the third year.

Your company’s presence or visibility at the event could indicate your company’s size and/or annual revenue. However, these factors (company size or revenue) are not used in calculating a compliance fine.

Your company’s visibility at an event is evaluated by your booth size, placement on the show floor, and any additional sponsorship programs your company has purchased in total for the last 3 years. In order of account spend for the last three years, the top 350 on this list are considered to have Premium visibility at the events. All others are considered regular visibility. 

It is not the volume or number of violations at an exhibit that is used to calculate the fine.  The presence of non-compliant claim(s) at an event, regardless of number, is one of the factors in determining the fine.

The compliance offense count will be tracked cumulatively across consecutive events at which you exhibit annually. Each offense is counted sequentially across the SupplySide events at which you participate in year after year, and your offense count progresses from first to second to third regardless of which specific SupplySide event the violation occurs at from year to year. This means that violations are not reset each calendar year or at each individual event. Once your company has had an exhibit that has been determined fully compliant, or if your company skips a year (does not exhibit), the offense count will reset to zero.

Compliance violations can be cleared with payment of the fine and confirmed resolution by the exhibitor. However, they remain a permanent part of your account history with us. Once your company has had an exhibit that has been determined fully compliant, or if your company skips a year (does not exhibit), the offense count will reset to zero.

If your company exhibits every year, after a third compliance offense, you may be asked to sit out or skip a year and return the following year to exhibit again. The frequency of offenses is counted sequentially across all SupplySide events you participate in annually. The offense count progresses from first to second to third per event regardless of which specific SupplySide event the violation occurs at. Once your company has had an exhibit that has been determined fully compliant, or if your company skips a year (does not exhibit), the offense count will reset to zero.

No. Non-compliant disease claims in an exhibit are a breach of your booth contract which states that you will adhere to the Compliance program.


Compliance Fine Notification, Billing and Payment, Usage & Effectiveness 

The review for compliance violations occurs onsite during the event. A member of our Standards team will visit your exhibit to review your marketing materials and booth display. If any non-compliant claims are found, you will receive a Standards review message within approximately two weeks after the event. This review message will include the non-compliant claims, the materials in which these claims were found, how much the compliance fine is, how the fine was calculated (see questions 17 and 18 above), and an approximate payment due date. We cannot foresee and calculate fines before an event. We can, however, pre-screen your marketing materials (and booth display) through our new pre-screening process to help you avoid post-event compliance fines.

Compliance fines will be added to your event billing statement approximately 1 month after the event at which the non-compliance matter occurred, on the same event statement for which the non-compliance occurred. The fine will be a separate line item on your statement. Compliance fines should be paid upon receipt. You may use the same payment methods as you use to pay for your booth. Non-payment may delay future booth reservations. You can apply a compliance fine to MarketReady regulatory consulting services. See next question.

You can apply your paid fine to MRI services within a 3-year period. After 3 years, the fine may not be applied to MRI services. 

A compliance fine should be paid in full as soon as you receive the invoice. We will allow 30 days for payment, after which time your account in our system will be flagged for non-payment. This could delay any future booth reservations.

The collected fines can be applied to any MarketReady Insights service that is available. Unused portions of these fines will go towards the continuing operations of the Compliance program, particularly the Pre-screening service.

We currently see 15-19% non-compliance at the events. Any reduction in this rate should indicate the effectiveness of the program over the first three years. We expect to see under 10% non-compliance after year 3 (2028 events).